GetTopicDetailResponse(id=bbe3e3748f5, topicName=碳青霉烯類抗生素, introduction=碳青霉烯類抗生素, content=null, image=null, comments=1, allHits=1252, url=https://h5.medsci.cn/topic?id=73748, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=40090, tagList=[TagDto(tagId=40090, tagName=碳青霉烯類抗生素)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2253816, encodeId=47cc2253816da, content=<a href='/topic/show?id=bbe3e3748f5' target=_blank style='color:#2F92EE;'>#碳青霉烯類抗生素#</a> <a href='/topic/show?id=9a94485e652' target=_blank style='color:#2F92EE;'>#帶量采購#</a>, objectTitle=主編推薦 ‖ 湖南省帶量采購和分級管理政策對碳青霉烯類抗生素利用的影響, objectType=article, longId=864228, objectId=13b286422820, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-working-in-a-hospital-PSQT2U3.jpg, objectUrl=/article/show_article.do?id=13b286422820, replyNumber=0, likeNumber=32, createdTime=2025-02-27, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=13b286422820, moduleTitle=主編推薦 ‖ 湖南省帶量采購和分級管理政策對碳青霉烯類抗生素利用的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=13b286422820)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2129617, encodeId=0234212961ea9, content=<a href='/topic/show?id=4b64e998681' target=_blank style='color:#2F92EE;'>#美羅培南#</a>與<a href='/topic/show?id=7e6e106042d0' target=_blank style='color:#2F92EE;'>#瓦博巴坦#</a>(也稱<a href='/topic/show?id=575a10604314' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=575a10604314' target=_blank style='color:#2F92EE;'>#法硼巴坦#</a></a>，Vaborem，Menarini)是一種廣譜<a href='/topic/show?id=bbe3e3748f5' target=_blank style='color:#2F92EE;'>#碳青霉烯類抗生素#</a>和一種新的<a href='/topic/show?id=e5e8191845d' target=_blank style='color:#2F92EE;'>#β-內(nèi)酰胺酶抑制劑#</a>的組合，前者覆蓋革蘭氏陽性菌、革蘭氏陰性菌和厭氧菌，后者可預(yù)防A類和C類(但不包括B類和D類)碳青霉烯類<a href='/topic/show?id=f5f955419b0' target=_blank style='color:#2F92EE;'>#抗生素#</a>(導(dǎo)致對碳青霉烯類抗生素產(chǎn)生耐藥性的酶)。
<a href='/topic/show?id=575a10604314' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=575a10604314' target=_blank style='color:#2F92EE;'>#法硼巴坦#</a></a> ( Vaborbactam)是一種以環(huán)狀硼酸藥效團為主的β-內(nèi)酰胺酶抑制劑。 法硼巴坦 是一種廣譜的β-內(nèi)酰胺酶抑制劑,對KPC,CTX-M,SHV和CMY酶具有特別強的活性。, objectTitle=2020 NICE 證據(jù)總結(jié)：抗菌處方：美羅培南與法硼巴坦【ES21】, objectType=guider, longId=22949, objectId=d40931c0030310c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=d40931c0030310c5, replyNumber=0, likeNumber=118, createdTime=2023-05-02, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d40931c0030310c5, moduleTitle=2020 NICE 證據(jù)總結(jié)：抗菌處方：美羅培南與法硼巴坦【ES21】, moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=d40931c0030310c5)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
2020-05-29
